Shree Ganesh Bio-Tech (India) Limited has announced the acquisition of a substantial stake in Suncare Traders Ltd, disclosing the transaction under SEBI's regulatory framework for substantial acquisitions. The disclosure was submitted to BSE Limited on March 24, 2026, detailing the acquisition of shares representing 5.28% of the target company's voting capital.

Acquisition Details

The transaction involved the purchase of 1,34,58,166 shares in Suncare Traders Ltd through open market and off-market operations. The acquisition was completed on March 22, 2026, marking Shree Ganesh Bio-Tech's entry as a significant shareholder in the target company.

Target Company Information

Suncare Traders Ltd is listed on BSE Limited with security code 539526 and scrip code SCTL. The company's equity share capital stands at Rs. 51,00,00,000 divided into 25,50,00,000 equity shares of Rs. 2.00 each. The capital structure remained unchanged following this acquisition, with the CIN number L51909GJ1997PLC03156.

Shareholding Pattern Changes

Prior to this acquisition, Shree Ganesh Bio-Tech held no shares in Suncare Traders Ltd. The company has confirmed that it does not belong to the promoter or promoter group of the target company. Post-acquisition, the shareholding details are as follows:

Regulatory Compliance

The disclosure was made in accordance with Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Shree Ganesh Bio-Tech (India) Limited, incorporated in 1982 with CIN L70101WB1982PLC121196, has its registered office in Kolkata and operates in the biotechnology sector. The company has submitted the required documentation to both BSE Limited and the compliance officer of Suncare Traders Ltd, ensuring full regulatory compliance for this substantial acquisition transaction.

Suncare Traders has witnessed significant shareholding changes with two major transactions involving 11.76% stakes. While Shah Enterprise completed its divestment, Nilmesh Infrabuild LLP has made a substantial acquisition in the company through an off-market transaction.

Official SEBI Disclosure Confirmation

Suncare Traders Ltd has officially submitted disclosures under Regulation 29(1) and 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 to BSE Limited. The company, with CIN L51909GJ1997PLC03156 and scrip code 539526, confirmed the receipt of disclosure documents via email on March 19, 2026.

Nilmesh Infrabuild LLP Acquisition Details

Nilmesh Infrabuild LLP has acquired a significant stake in Suncare Traders Ltd through an off-market transaction. The acquisition was disclosed under Regulation 29(1) of SEBI regulations, with Albert acting as the authorized signatory and partner for the acquiring entity.

Shah Enterprise Divestment Transaction

Shah Enterprise completed the sale of its entire 11.76% stake in Suncare Traders Ltd through an off-market transaction on March 19, 2026. The disclosure under Regulation 29(2) confirms the complete exit of Shah Enterprise from the company.

Company Share Capital Structure

Suncare Traders Ltd maintains a consistent equity share capital structure throughout both transactions. The company's share capital remains unchanged at Rs. 51,00,00,000 divided into 25,50,00,000 equity shares of Rs. 2.00 each.

Regulatory Compliance and Documentation

Both transactions have been properly documented and submitted to BSE Limited and the compliance officer of Suncare Traders Ltd. The disclosures ensure full compliance with SEBI regulations governing substantial shareholding acquisitions and disposals in listed companies. The authorized signatories from both entities have completed the required documentation under the applicable SEBI regulations.